Anurag Pokhra

Director

India's orthopedic healthcare market is witnessing sus­tained growth, driven by an aging population, rising in­cidences of osteoporosis and arthritis, sports-related in­juries, and increasingly sedentary lifestyles that contribute to musculoskeletal disorders.

Alongside these demograph­ic and lifestyle shifts, healthcare professionals are placing greater emphasis on preventive bone health, nutritional supplementation, rehabilitation, and evidence-based pain management.

Operating within this dynamic landscape, ARRIDE Healthcare has steadily built a reputation as a spe­cialty pharmaceutical company focused on orthopedic and women's healthcare solutions. Established in 2010, the com­pany has combined quality-focused manufacturing partner­ships, ethical business practices, and strong engagement with healthcare professionals to create a growing portfolio of affordable, clinically relevant products.

Rather than com­peting solely on scale, ARRIDE Healthcare has differentiat­ed itself through consistency, scientific engagement, and a long-term commitment to delivering dependable healthcare solutions that support both physicians and patients.

Building a Specialty Pharmaceutical Company on Strong Foundations

The foundation of ARRIDE Healthcare is closely linked to the professional journey of its founder, whose academic background in science and management, coupled with more than seven years of experience at Unichem Pharmaceuticals, shaped the company's vision. Exposure to pharmaceutical sales, marketing, customer engagement, and physician interactions provided valuable insight into the evolving needs of India's healthcare ecosystem and highlighted the importance of delivering accessible, quality medicines supported by ethical practices.

Established on 6 July 2010, ARRIDE Healthcare began with a focused product portfolio and a clear objective of becoming a trusted pharmaceutical partner for healthcare professionals. Over the years, the company has expanded its offerings to more than 45 products across Orthopedics and Gynecology, supported by a dedicated team comprising medical representatives and an expanding network of distributors and stockists. This measured yet consistent growth reflects a business strategy centered on sustainable expansion rather than rapid diversification.

“The company's vision extends beyond commercial success. ARRIDE Healthcare aims to improve patient outcomes by delivering reliable pharmaceutical solutions while creating long-term value for doctors, channel partners, and patients through quality, affordability, and professional integrity”, says Anurag Pokhra, Director.

A Comprehensive Portfolio Supporting Musculoskeletal Health

As orthopedic care increasingly shifts toward holistic management that integrates prevention, treatment, rehabilitation, and nutritional support, ARRIDE Healthcare has expanded its portfolio to address multiple stages of patient care.

Its orthopedic product range includes calcium supplements, Vitamin D3 formulations, nutraceuticals, anti-inflammatory medicines, muscle support therapies, and pain management solutions designed to support bone health and faster recovery. Flagship brands such as Waftcal-MAX, Waftcal-CC, GRFCAL-D3, Vontafil, Esob-D, Qustagab-MNT, and Qustagab-NT cater to various musculoskeletal health requirements, while pain management offerings including Coxjet-90, Coxjet-MR, Dicqua-SP, and Dicqua Gel address inflammation and pain relief.

The company has also strengthened its nutraceutical portfolio with formulations such as Qusta Joint, Qustaroz-3, Qustagem, Qustagem-L, and Qustagem-Q10, supporting long-term joint health and recovery. Complementing its orthopedic business, ARRIDE Healthcare has established a Women's Healthcare division offering products for hormone therapy, fertility support, and gynecological care, enabling the company to diversify within specialty pharmaceutical segments while maintaining clinical relevance.

By continuously evaluating therapeutic trends and healthcare professionals' feedback, ARRIDE Healthcare seeks to ensure that its portfolio remains aligned with evolving patient needs and contemporary treatment practices.

Quality, Scientific Engagement, and Ethical Growth

One of ARRIDE Healthcare's defining strengths lies in its unwavering focus on product quality and professional credibility. Rather than investing in proprietary manufacturing facilities, the company collaborates with WHO-GMP and ISO-certified manufacturing partners that adhere to stringent quality assurance protocols. Laboratory-certified raw materials, comprehensive quality control processes, and stability studies collectively ensure that products meet established standards for safety, consistency, and efficacy.

“Beyond manufacturing excellence, ARRIDE Healthcare places considerable emphasis on scientific engagement. Through Continuous Medical Education (CME) programs and regular interactions with healthcare professionals, the company promotes clinical awareness while gaining valuable insights into changing therapeutic requirements. This collaborative approach supports evidence-based product development and strengthens relationships with physicians who increasingly seek dependable pharmaceutical partners capable of delivering both quality products and clinical value”, mentions Anurag Pokhra.

Ethical marketing practices, reliable product availability, and responsive customer support have further reinforced ARRIDE Healthcare's credibility within its operating markets, enabling it to cultivate long-standing partnerships built on trust rather than transactional engagement.

Scaling with Innovation and a Long-Term Vision

Competing against significantly larger pharmaceutical companies has been one of ARRIDE Healthcare's most notable challenges. Instead of pursuing aggressive expansion, the company has focused on strengthening customer relationships, selecting dependable manufacturing partners, and building a committed field force capable of delivering consistent service. This disciplined strategy has enabled ARRIDE Healthcare to achieve approximately 25 percent annual growth while recording an annual turnover of around ?2.4 crore, demonstrating that sustained progress can be driven by quality, credibility, and customer confidence.

Looking ahead, the company plans to strengthen its presence across Orthopedics, Pain & Inflammation, Hormone Therapy, and Infertility Management while expanding its product portfolio and geographical reach. A significant strategic initiative is the development of a nationwide digital pharma franchise platform aimed at strengthening distribution across India. Alongside business expansion, ARRIDE Healthcare continues to support healthcare camps and medicine distribution initiatives through NGOs, reflecting its broader commitment to improving healthcare accessibility.

As India's specialty pharmaceutical sector continues to evolve, ARRIDE Healthcare is positioning itself as a trusted partner that combines quality manufacturing, ethical leadership, scientific collaboration, and patient-centric innovation to contribute meaningfully to the future of orthopedic healthcare.